This research shows the clinical accuracy of the OneTouch Select Plus® platform and shows the value of a continuous and systematic testing program to verify product performance as long as it is available to patients. CHESTERBROOK, Pa., February 8, 2019 / PRNewswire / - - New research published in a leading journal in diabetes technology shows the long-term clinical accuracy of the OneTouch Select Plus® blood glucose test strip platform and highlights constant and accurate product performance. . This is the latest study in a series of recent studies that confirm the accuracy of the OneTouch® blood glucose monitoring system. A study published this week in the Journal of Diabetes Science and Technology (JDST) details three years of proven accuracy from the OneTouch Select Plus® blood glucose monitoring platform in various clinical trials in patients with diabetes. The results of this study come from more than 21,000 data points from more than 200 different batch test strips launched since the launch of the OneTouch Select Plus® test strip in 2015. The results show that the system meets the minimum requirements of the International Organization for Standardization (ISO 15197 Standard: 2013 and the harmonized European version EN ISO 15197: 2015, with an average of 97.6% of the results in the specification, which shows the accuracy and consistency of the product. [1]
"This study is an example of the clinical rigidity and importance of LifeScan applicable to its after-sales program, which I consider to be a recommended practice for diabetic device companies," Dr. Guido Freckmann, Medical Director of the Institute for Diabetes - Technologie Forschungs-Entwicklungsgesellschaft MBH an der Universität Ulm and leading expert in precision blood glucose monitoring. "In this study, the results were based on more than 21,000 readings of blood glucose meters collected in clinical settings and compared with appropriate readings of reference instruments, all with the OneTouch Select Plus® test strip, during the period Type of continuous and systematic analysis of the testing methodology this enhances the performance image provided by other precision studies, including those I have written. "
This study is the latest in a series of studies that highlight the accuracy of the OneTouch® blood glucose monitoring system. In the JDST study in March 2018, leading experts in self-monitoring of blood glucose (BG) tested the OneTouch Verio Flex® blood glucose monitoring system and found that "this new system shows a high level of measurement accuracy" Three batches tested meet and exceed requirements minimum standard 15197: 2013 from the International Organization for Standardization (ISO) for system accuracy [.2]Studi ini mengikuti publikasi studi ketiga dalam edisi April 2017 jurnal yang sama yang merinci tujuh tahun keakuratan platform OneTouch Verio® yang telah terbukti di lebih dari 70.000 titik data klinis. [3]
"Swa-monitor glukosa darah tetap menjadi cara yang paling akurat, efektif, dan terjangkau bagi penderita diabetes untuk melacak kadar gula darah mereka," kata Dr. David Shearer, Direktur Senior Matters. Dokter Dunia dan Petugas Keamanan Senior, LifeScan, Inc. "OneTouch Select Plus® dan sistem pemantauan glukosa darah OneTouch Verio®, kami dengan bangga menawarkan kepada penderita diabetes dan tim perawatan mereka produk yang sangat akurat pada mereka yang tahu mereka bisa percaya. "
Sistem Pemantauan Glukosa Darah OneTouch Select Plus® dan Strip Tes OneTouch Select Plus® dan Sistem Pemantauan Glukosa Darah OneTouch Verio Flex dan OneTouch Verio® Test Strips ditawarkan dari merek OneTouch® ikon dari LifeScan. . Ketersediaan produk bervariasi di setiap negara. Tiga studi yang disebutkan dalam Jurnal Ilmu dan Teknologi Diabetes didanai secara keseluruhan atau sebagian oleh LifeScan.
Tentang LifeScan, Inc. Dengan visi untuk menciptakan dunia tanpa batas bagi penderita diabetes, LifeScan, Inc. adalah pemimpin global dalam pemantauan glukosa darah: lebih dari 20 juta orang di seluruh dunia bergantung pada Produk merek OneTouch® untuk membantu Anda mengelola diabetes Anda. Selama lebih dari 35 tahun, LifeScan telah memiliki komitmen yang tak tergoyahkan untuk meningkatkan kualitas hidup penderita diabetes dengan mengembangkan produk yang ditentukan oleh kesederhanaan, ketepatan dan kepercayaan diri. Untuk informasi lebih lanjut, kunjungi www.LifeScan.com dan www.OneTouch.com.
[1] Setford, et al. Bukti program pengawasan pasca-pasar sistematis jangka panjang yang sistematis; Kinerja klinis dari strip tes glukosa darah tidak sensitif terhadap hematokrit. Jurnal Ilmu dan Teknologi Diabetes (2019) 1-9
[2] Annette Baumstark, PhD, Nina Jendrike, MD, Stefan Pleus, MSc, Christina Liebing, PhD, Cornelia Haug, MD, dan Guido Freckmann, MDA Evaluasi akurasi sistem baru untuk swa-monitor glukosa darah dengan tiga strip bukti Berdasarkan ISO 15197: 2013 (Journal of Diabetes Science and Technology (2017) 1-2